AVR-话题@MedSci

#AVR#

154篇内容 | 1092人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2086426, encodeId=cd942086426ee, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关, objectType=article, longId=739778, objectId=d509e3977819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d509e3977819, replyNumber=0, likeNumber=38, createdTime=2023-07-17, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d509e3977819, moduleTitle=TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d509e3977819)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086423, encodeId=ce762086423ac, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=circulation：依度沙班与双重抗血小板疗法治疗TAVR术后脑血栓没有差异, objectType=article, longId=723785, objectId=2d77e2378575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d77e2378575, replyNumber=0, likeNumber=59, createdTime=2023-03-04, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d77e2378575, moduleTitle=circulation：依度沙班与双重抗血小板疗法治疗TAVR术后脑血栓没有差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d77e2378575)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086425, encodeId=d0f8208642508, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗, objectType=article, longId=739756, objectId=389fe3975635, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=389fe3975635, replyNumber=0, likeNumber=49, createdTime=2023-04-05, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=389fe3975635, moduleTitle=TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=389fe3975635)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086424, encodeId=96452086424e7, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=European Radiology：基于机器学习的CT-FFR对TAVR术严重主动脉狭窄患者决策的影响, objectType=article, longId=736812, objectId=e14ce36812ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e14ce36812ec, replyNumber=0, likeNumber=36, createdTime=2022-09-30, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e14ce36812ec, moduleTitle=European Radiology：基于机器学习的CT-FFR对TAVR术严重主动脉狭窄患者决策的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e14ce36812ec)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086422, encodeId=76342086422f1, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JACC：Ross手术的预后明显优于生物瓣膜AVR！, objectType=article, longId=300625, objectId=f8f33006258f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f33006258f, replyNumber=0, likeNumber=58, createdTime=2022-12-03, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f33006258f, moduleTitle=JACC：Ross手术的预后明显优于生物瓣膜AVR！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8f33006258f)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086421, encodeId=d0c72086421ef, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JAHA：TAVR的房颤患者直接口服抗凝剂的使用情况和结局, objectType=article, longId=293338, objectId=2b43293338d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b43293338d4, replyNumber=0, likeNumber=47, createdTime=2022-09-11, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b43293338d4, moduleTitle=JAHA：TAVR的房颤患者直接口服抗凝剂的使用情况和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b43293338d4)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086420, encodeId=c0eb2086420e8, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, objectType=article, longId=221433, objectId=288d221433d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288d221433d2, replyNumber=0, likeNumber=35, createdTime=2022-01-04, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288d221433d2, moduleTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=288d221433d2)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086414, encodeId=1fa0208641498, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=不开刀，换心瓣！肇庆地区完成首例TAVR手术, objectType=article, longId=209353, objectId=34ee209353c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ee209353c5, replyNumber=0, likeNumber=33, createdTime=2022-01-07, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ee209353c5, moduleTitle=不开刀，换心瓣！肇庆地区完成首例TAVR手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34ee209353c5)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086419, encodeId=2642208641961, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂, objectType=article, longId=216443, objectId=41892164434e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41892164434e, replyNumber=0, likeNumber=0, createdTime=2021-11-18, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41892164434e, moduleTitle=2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41892164434e)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086417, encodeId=28b1208641ed1, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果, objectType=article, longId=213457, objectId=862e21345e3a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=862e21345e3a, replyNumber=0, likeNumber=35, createdTime=2021-08-05, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=862e21345e3a, moduleTitle=Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=862e21345e3a)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086415, encodeId=8eda208641574, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=avRp波倒置，下壁导联p波倒置，考虑房性还是窦性的？, objectType=article, longId=211865, objectId=51d02118653b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51d02118653b, replyNumber=0, likeNumber=37, createdTime=2021-08-24, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51d02118653b, moduleTitle=avRp波倒置，下壁导联p波倒置，考虑房性还是窦性的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51d02118653b)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086418, encodeId=38ee2086418dc, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=双瓣膜病变伴冠脉高险 | 江西省心血管病医院洪浪院长带领团队顺利完成1例一站式PBMV+TAVR冠脉高风险手术, objectType=article, longId=213900, objectId=58c62139002b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c62139002b, replyNumber=0, likeNumber=33, createdTime=2022-03-08, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c62139002b, moduleTitle=双瓣膜病变伴冠脉高险 | 江西省心血管病医院洪浪院长带领团队顺利完成1例一站式PBMV+TAVR冠脉高风险手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c62139002b)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086416, encodeId=4e722086416f9, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=短阵宽QRS波，若无室性早搏，考虑室速还是逆向性AVRT？还是其它？, objectType=article, longId=212193, objectId=1e4e2121936e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4e2121936e, replyNumber=0, likeNumber=37, createdTime=2022-02-05, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4e2121936e, moduleTitle=短阵宽QRS波，若无室性早搏，考虑室速还是逆向性AVRT？还是其它？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4e2121936e)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086405, encodeId=2790208640531, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JACC：当心源性休克早于TAVR时的人口学、手术特征和临床结局, objectType=article, longId=195616, objectId=bbdf19561680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbdf19561680, replyNumber=0, likeNumber=0, createdTime=2020-12-08, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbdf19561680, moduleTitle=JACC：当心源性休克早于TAVR时的人口学、手术特征和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbdf19561680)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086413, encodeId=821e2086413cf, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=FDA批准Gavreto（pralsetinib）治疗转移性RET融合阳性非小细胞肺癌, objectType=article, longId=200381, objectId=9ed320038179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ed320038179, replyNumber=0, likeNumber=41, createdTime=2021-03-17, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ed320038179, moduleTitle=FDA批准Gavreto（pralsetinib）治疗转移性RET融合阳性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ed320038179)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086407, encodeId=8cc4208640ee6, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JAHA：右心室收缩功能障碍对TAVR术后短期结局的影响, objectType=article, longId=195923, objectId=d74619592302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d74619592302, replyNumber=0, likeNumber=26, createdTime=2021-02-10, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d74619592302, moduleTitle=JAHA：右心室收缩功能障碍对TAVR术后短期结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d74619592302)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086399, encodeId=a7e92086399ce, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JACC子刊：使用球囊扩张与自扩张瓣膜进行TAVR的5年结局比较, objectType=article, longId=194029, objectId=ffcf194029af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffcf194029af, replyNumber=0, likeNumber=45, createdTime=2021-03-24, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffcf194029af, moduleTitle=JACC子刊：使用球囊扩张与自扩张瓣膜进行TAVR的5年结局比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffcf194029af)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086403, encodeId=d8842086403a3, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=中山医院葛均波院士团队成功完成我国首例TAVR瓣膜衰败再TAVR手术, objectType=article, longId=195595, objectId=ed61195595b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed61195595b5, replyNumber=0, likeNumber=28, createdTime=2021-04-14, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed61195595b5, moduleTitle=中山医院葛均波院士团队成功完成我国首例TAVR瓣膜衰败再TAVR手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed61195595b5)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086398, encodeId=5e7f208639886, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JACC子刊：症状性严重二叶式主动脉瓣狭窄低风险患者的TAVR , objectType=article, longId=194025, objectId=0269194025a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0269194025a3, replyNumber=0, likeNumber=44, createdTime=2021-02-15, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0269194025a3, moduleTitle=JACC子刊：症状性严重二叶式主动脉瓣狭窄低风险患者的TAVR , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0269194025a3)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2086391, encodeId=67a920863918a, content=<a href='/topic/show?id=134b304456' target=_blank style='color:#2F92EE;'>#AVR#</a>, objectTitle=JACC：接受TAVR低流量、低梯度主动脉瓣狭窄患者的二尖瓣返流, objectType=article, longId=190094, objectId=8144190094c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8144190094c8, replyNumber=0, likeNumber=32, createdTime=2020-10-09, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8144190094c8, moduleTitle=JACC：接受TAVR低流量、低梯度主动脉瓣狭窄患者的二尖瓣返流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8144190094c8)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

AVR

2020-05-29

(审核中...)

前往app查看评论内容

#AVR#

TCT 2022：患者-人工瓣膜不匹配（PPM）与TAVR术后死亡率增加有关

2023-07-17

(审核中...)

前往app查看评论内容

#AVR#

circulation：依度沙班与双重抗血小板疗法治疗TAVR术后脑血栓没有差异

2023-03-04

(审核中...)

前往app查看评论内容

#AVR#

TCT 2022：TAVR 和 SAVR 治疗趋势，近50%重度主动脉瓣狭窄患者进行TAVR治疗

2023-04-05

(审核中...)

前往app查看评论内容

#AVR#

European Radiology：基于机器学习的CT-FFR对TAVR术严重主动脉狭窄患者决策的影响

2022-09-30

(审核中...)

前往app查看评论内容

#AVR#

JACC：Ross手术的预后明显优于生物瓣膜AVR！

2022-12-03

(审核中...)

前往app查看评论内容

#AVR#

JAHA：TAVR的房颤患者直接口服抗凝剂的使用情况和结局

2022-09-11

(审核中...)

前往app查看评论内容

#AVR#

NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较

2022-01-04

(审核中...)

前往app查看评论内容

#AVR#

不开刀，换心瓣！肇庆地区完成首例TAVR手术

2022-01-07

(审核中...)

前往app查看评论内容

#AVR#

2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂

2021-11-18

(审核中...)

前往app查看评论内容

#AVR#

Hum Vaccin Immunother：甲肝疫苗Healive®和Havrix®在儿童中的免疫原性的持续性：11年随访观察结果

2021-08-05

(审核中...)

前往app查看评论内容

#AVR#

avRp波倒置，下壁导联p波倒置，考虑房性还是窦性的？

2021-08-24

(审核中...)

前往app查看评论内容

#AVR#

双瓣膜病变伴冠脉高险 | 江西省心血管病医院洪浪院长带领团队顺利完成1例一站式PBMV+TAVR冠脉高风险手术

2022-03-08

(审核中...)

前往app查看评论内容

#AVR#

短阵宽QRS波，若无室性早搏，考虑室速还是逆向性AVRT？还是其它？

2022-02-05

(审核中...)

前往app查看评论内容

#AVR#

JACC：当心源性休克早于TAVR时的人口学、手术特征和临床结局

2020-12-08

(审核中...)

前往app查看评论内容

#AVR#

FDA批准Gavreto（pralsetinib）治疗转移性RET融合阳性非小细胞肺癌

2021-03-17

(审核中...)

前往app查看评论内容

#AVR#

JAHA：右心室收缩功能障碍对TAVR术后短期结局的影响

2021-02-10

(审核中...)

前往app查看评论内容

#AVR#

JACC子刊：使用球囊扩张与自扩张瓣膜进行TAVR的5年结局比较

2021-03-24

(审核中...)

前往app查看评论内容

#AVR#

中山医院葛均波院士团队成功完成我国首例TAVR瓣膜衰败再TAVR手术

2021-04-14

(审核中...)

前往app查看评论内容

#AVR#

JACC子刊：症状性严重二叶式主动脉瓣狭窄低风险患者的TAVR

2021-02-15

(审核中...)

前往app查看评论内容

#AVR#

JACC：接受TAVR低流量、低梯度主动脉瓣狭窄患者的二尖瓣返流

2020-10-09

科室
- - 订阅+
  - 更多科室
工具
服务